SmithKline Beckman
Executive Summary
Chairman Robert Dee, 62, to retire and step down from the board on April 22 after 38 years with the company. Dee joined SmithKline as a trainee in 1948 and was elected president in 1972 and chairman in 1976. With the exception of C. Mehlon Kline (1945-1958), Dee served as SmithKline chairman longer than anyone in this century. Dee was the top officer at SmithKline during the Tagamet development era. In recent years, Dee has participated actively in D.C. lobbying. Dee, for example, chaired PMA's tax committee from 1983-86, helping to preserve Section 936 in the most recent tax bill. He was also active in broader business policy issues, as a member of the Business Roundtable from 1976-82 and, most recently, as chairman of the National Association of Manufacturers. Dee's departure sets the stage for titular progression at SmithKline. The company has announced that President and CEO Henry Wendt will succeed Dee as chairman; recently-appointed Chief Operating Officer George Ebright appears in line to assume presidency.
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.